1. Home
  2. IPO
  • Earkart Limited IPO
Earkart Limited

Earkart IPO

  • Status: Closed
  • RHP:
  • ₹ 270,000 / 2000 shares

    Minimum Investment

Earkart IPO Details

  • Open Date

    25 Sep 2025

  • Close Date

    29 Sep 2025

  • Listing Date

    03 Oct 2025

  • IPO Price Range

    ₹ 135

  • IPO Size

    ₹ 49.26 Cr

  • Listing Exchange

    BSE SME

Open Free Demat Account

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

Earkart IPO Timeline

Earkart IPO Subscription Status

Last Updated: 29 September 2025 7:48 PM by 5paisa

Earkart Limited was incorporated in April 2021 as a private limited company and later converted into a public limited company in December 2024. Headquartered in Delhi with a corporate office in Noida, the company operates in the health-tech and assistive device sector. It specialises in the manufacture, distribution, and trading of hearing aids, their parts and accessories, as well as related healthcare products. Alongside, it also offers mobility aids such as foldable walkers and educational kits for persons with physical or sensory disabilities.

Earkart differentiates itself through its “shop-in-shop” model, which places hearing aid retail points inside ENT and ophthalmic clinics. This is further strengthened by its integration of digital audiometry and remote hearing test facilities, making access more convenient for patients.

Established year: 2021

Managing Director: Rohit Misra

Peers:
OSEL Devices Limited

Earkart Objectives

1. Funding incremental working capital requirements
2. Capital expenditure for “shop-in-shop” clinic expansion
3. Building core infrastructure for operational growth
4. Meeting general corporate purposes
5. Providing partial exit for promoter through Offer for Sale
 

Earkart IPO Size

Types Size
Total IPO Size ₹ 49.26 Cr
Offer For Sale ₹ 4.5 Cr
Fresh Issue ₹ 44.76 Cr

Earkart IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2000 2,70,000
Retail (Max) 2 2000 2,70,000

Profit and Loss

Balance Sheet

Particulars (In ₹Crores.) FY22 FY23 FY24
Revenue 5.69 28.91 31.75
EBITDA 0.13 1.60 3.55
PAT 0.10 1.31 3.05
Particulars (In ₹Crores.) FY22 FY23 FY24
Total Assets 5.94 14.72 19.25
Share Capital 6.74 6.77 6.91
Total Borrowing 0.25 1.21 4.00
Particulars (In ₹Crores.) FY22 FY23 FY24
Net Cash Generated From / (used in) operating activities -2.82 -0.29 -0.99
Net Cash Generated From / (used in) Investing Activities -1.77 0.39 -1.29
Net Cash Generated From / (used in) financing activities 4.68 -0.40 1.28
Net Increase (Decrease) In Cash And Cash Equivalents 0.072 0.51 0.79


Strengths

1. Niche focus in assistive devices
2. Integration with clinic networks
3. Technology and remote audiometry capability
4. Low debt, improving profitability
 

Weaknesses

1. Early stage, limited track record
2. Dependence on third-party clinics
3. Thin margins initially
4. Scalability challenges

Opportunities

1. Penetration into underserved regions
2. Growth in ageing, hearing-impaired population
3. Tie-ups with hospitals and NGOs
4. Government schemes supporting assistive devices

Threats

1. Regulatory and compliance risks
2. Competition from established players
3. Supply chain or component risk
4. Market adoption and awareness challenges

1. Consistent revenue and profit growth
2.Under-penetrated segment with high potential
3. Differentiated “shop-in-shop” clinic model
4. Competitive edge via digital audiometry
5. Aligned promoter with partial exit liquidity
6. Positive policy and healthcare tailwinds
7. Potential for listing gains and long-term returns
 

The Indian assistive device and hearing aid market remains under-penetrated, with significant gaps in accessibility and affordability. Rising awareness, growing disposable incomes, and increased healthcare infrastructure expansion across smaller cities present strong opportunities. Earkart’s unique model of embedding retail points within ENT and ophthalmic clinics positions it to capture demand at the point of diagnosis, reducing marketing and acquisition costs. With digital audiometry and remote testing solutions, the company also addresses convenience and scalability. The ageing population and rising incidence of hearing loss further create a long-term growth runway. However, execution will be key—success will depend on scaling efficiently, maintaining compliance, and expanding into under-served regions.

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Earkart IPO opens from September 25, 2025 to September 29, 2025.

The size of EarkartIPO is ₹49.26 Cr.

The price band of Earkart IPO is fixed at ₹135 per share.
 

To apply for Earkart IPO, follow the steps given below:
 
●    Login to your 5paisa demat account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for the Earkart IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    
 
You will receive a mandate notification to block funds in your UPI app.

The minimum lot size of the Earkart IPO is of 2000 shares and the investment required is ₹2,70,000.

The share allotment date of Earkart IPO is October 1, 2025

The Earkart IPO will likely be listed on October 3, 2025.

Sarthi Capital Advisors Pvt.Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue.

Earkart plans to utilise the raised capital from the IPO for:

1. Funding incremental working capital requirements
2. Capital expenditure for “shop-in-shop” clinic expansion
3. Building core infrastructure for operational growth
4. Meeting general corporate purposes
5. Providing partial exit for promoter through Offer for Sale